Stance Capital LLC Merck & Co., Inc. Transaction History
Stance Capital LLC
- $161 Billion
- Q4 2024
A detailed history of Stance Capital LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Stance Capital LLC holds 2,017 shares of MRK stock, worth $171,848. This represents 0.12% of its overall portfolio holdings.
Number of Shares
2,017Holding current value
$171,848% of portfolio
0.12%Shares
1 transactions
Others Institutions Holding MRK
# of Institutions
3,915Shares Held
1.85BCall Options Held
16MPut Options Held
15M-
Vanguard Group Inc Valley Forge, PA251MShares$21.4 Billion0.45% of portfolio
-
Black Rock Inc. New York, NY207MShares$17.7 Billion0.59% of portfolio
-
State Street Corp Boston, MA121MShares$10.3 Billion0.49% of portfolio
-
Geode Capital Management, LLC Boston, MA61.2MShares$5.21 Billion0.48% of portfolio
-
Morgan Stanley New York, NY44.2MShares$3.76 Billion0.32% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $216B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...